| Literature DB >> 28333988 |
Marek Bryla1, Elzbieta Dziankowska-Zaborszczyk2, Pawel Bryla3, Malgorzata Pikala2, Irena Maniecka-Bryla2.
Abstract
PURPOSE: An evaluation of mortality due to infectious diseases in Poland in 1999-2012 and an analysis of standard expected years of life lost due to the above diseases.Entities:
Mesh:
Year: 2017 PMID: 28333988 PMCID: PMC5363939 DOI: 10.1371/journal.pone.0174391
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
CDR and SDR (per 100,000 population) due to infectious diseases in Poland in 1999–2012 by sex.
| Years | CDR | SDR | ||||
|---|---|---|---|---|---|---|
| Men | Women | Total | Men | Women | Total | |
| 1999 | 8.95 | 4.62 | 6.72 | 10.27 | 4.35 | 6.96 |
| 2000 | 9.32 | 5.01 | 7.10 | 10.54 | 4.52 | 7.19 |
| 2001 | 8.70 | 4.74 | 6.66 | 9.66 | 4.26 | 6.64 |
| 2002 | 8.83 | 4.99 | 6.85 | 9.78 | 4.37 | 6.76 |
| 2003 | 9.21 | 4.59 | 6.82 | 10.05 | 3.81 | 6.52 |
| 2004 | 8.54 | 4.52 | 6.47 | 9.19 | 3.75 | 6.12 |
| 2005 | 8.82 | 4.63 | 6.66 | 9.27 | 3.78 | 6.20 |
| 2006 | 8.76 | 4.97 | 6.81 | 9.12 | 4.01 | 6.28 |
| 2007 | 8.49 | 4.81 | 6.59 | 8.62 | 3.81 | 5.96 |
| 2008 | 9.72 | 5.84 | 7.71 | 9.70 | 4.50 | 6.82 |
| 2009 | 9.77 | 6.27 | 7.96 | 9.71 | 4.69 | 6.90 |
| 2010 | 9.69 | 6.13 | 7.85 | 9.46 | 4.27 | 6.60 |
| 2011 | 10.24 | 7.15 | 8.64 | 9.88 | 4.96 | 7.14 |
| 2012 | 8.24 | 6.12 | 7.14 | 7.76 | 4.05 | 5.75 |
CDR = crude death rate; SDR = standardized death rate
Fig 1SDR trends due to infectious diseases (per 100,000 population) and annual percentage change, for the total population of Poland and by sex in 1999–2012.
Changes in SDR trends due to the selected infectious diseases in Poland in 1999–2012 by sex.
| Causes of death | Number of joinpoints | Period | APC 95% CI | AAPC 95%CI | |
|---|---|---|---|---|---|
| Infectious and parasitic diseases (A00-B99, G00, G03-G04, N70-N73) | Total | 0 | 1999–2012 | -0.51 (-1.5; 0.5) | |
| Men | 0 | 1999–2012 | -1.05* (-2.0; -0.2) | ||
| Women | 0 | 1999–2012 | 0.35 (-0.9; 1.7) | ||
| Intestinal infectious diseases (A00-A09) | Total | 1 | 1999–2006 | -8.97* (-14.1; -3.5) | 7.3* (3.1; 11.7) |
| 2006–2012 | 30.11* (20.9; 40.1) | ||||
| Men | 1 | 1999–2006 | -11.69* (-19.0; -3.7) | 6.7* (0.5; 13.2) | |
| 2006–2012 | 32.92* (19.1; 48.4) | ||||
| Women | 1 | 1999–2005 | -9.90* (-17.8; -1.2) | 7.4* (2.2; 12.9) | |
| 2005–2012 | 24.87* (16.1; 34.3) | ||||
| Tuberculosis (A15-A19) | Total | 0 | 1999–2012 | -5.40* (-6.3; -4.5) | |
| Men | 0 | 1999–2012 | -5.49* (-6.3; -4.6) | ||
| Women | 0 | 1999–2012 | -6.00* (-7.5; -4.4) | ||
| Other bacterial diseases (A30-A49) | Total | 0 | 1999–2012 | 3.63* (1.6; 5.7) | |
| Men | 0 | 1999–2012 | 4.46* (2.0; 7.0) | ||
| Women | 0 | 1999–2012 | -2.98* (-1.1; -4.9) | ||
| Viral hepatitis (B15-B19) | Total | 1 | 1999–2010 | -1.74* (-2.7; -0.0) | 0.6 (-1.5; 2.8) |
| 2010–2012 | 10.31 (-5.4; 28.6) | ||||
| Men | 0 | 1999–2012 | -1.74*(-2.7; -0.7) | ||
| Women | 0 | 1999–2012 | 1.53 (-0.4; 3.5) | ||
| Human immunodeficiency virus [HIV] disease (B20-24) | Total | 0 | 1999–2012 | 0.37 (-1.2; 1.9) | |
| Men | 0 | 1999–2012 | 0.27 (-1.7; 2.3) | ||
| Women | 0 | 1999–2012 | 0.65 (-1.9; 3.3) | ||
| Bacterial meningitis, not elsewhere classified (G00) | Total | 1 | 1999–2001 | -21.67 (-41.1; 4.2) | -3.6 (-7.4; 0.4) |
| 2001–2012 | 0.14 (-1.8; 2.1) | ||||
| Men | 1 | 1999–2001 | -21.74 (-43.9; 9.3) | -3.6 (-8.0; 1.1) | |
| 2001–2012 | 0.18 (-2.1; 2.5) | ||||
| Women | 0 | 1999–2012 | -2.18 (-4.8; 0.5) | ||
| Meningitis due to other and unspecified causes, encephalitis, myelitis and encephalomyelitis (G03-G04) | Total | 0 | 1999–2012 | -3.42* (-4.7; -2.1) | |
| Men | 0 | 1999–2012 | -2.71* (-4.9; -0.5) | ||
| Women | 0 | 1999–2012 | -4.27* (-6.0; -2.5) |
(* p<0.05)
Years of life lost due to infectious diseases in Poland in 1999–2012 by sex (values discounted by time and weighted by age).
| Years | SEYLL | SEYLLp*10,000 | SEYLLd | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Men | Women | Total | Men | Women | Total | Men | Women | Total | |
| 1999 | 24462.40 | 12406.48 | 36868.87 | 13.10 | 6.27 | 9.59 | 14.63 | 13.57 | 14.26 |
| 2000 | 24581.78 | 12144.52 | 36726.30 | 13.26 | 6.16 | 9.60 | 14.22 | 12.30 | 13.52 |
| 2001 | 22689.56 | 11464.44 | 34154.00 | 12.24 | 5.81 | 8.93 | 14.08 | 12.27 | 13.41 |
| 2002 | 22768.47 | 11606.11 | 34374.57 | 12.30 | 5.89 | 8.99 | 13.93 | 11.78 | 13.13 |
| 2003 | 23377.02 | 10362.08 | 33739.10 | 12.64 | 5.26 | 8.83 | 13.73 | 11.46 | 12.94 |
| 2004 | 20863.79 | 10002.86 | 30866.65 | 11.29 | 5.08 | 8.08 | 13.22 | 11.23 | 12.50 |
| 2005 | 21903.22 | 10103.94 | 32007.17 | 11.86 | 5.13 | 8.39 | 13.45 | 11.08 | 12.60 |
| 2006 | 22076.48 | 10990.47 | 33066.95 | 11.97 | 5.58 | 8.67 | 13.66 | 11.21 | 12.74 |
| 2007 | 20818.92 | 10088.83 | 30907.76 | 11.30 | 5.12 | 8.11 | 13.32 | 10.64 | 12.31 |
| 2008 | 23560.18 | 12377.64 | 35937.82 | 12.80 | 6.28 | 9.43 | 13.17 | 10.75 | 12.22 |
| 2009 | 22668.81 | 12763.22 | 35432.03 | 12.31 | 6.47 | 9.29 | 12.59 | 10.32 | 11.67 |
| 2010 | 22025.16 | 10604.16 | 32629.32 | 11.88 | 5.35 | 8.51 | 12.26 | 8.73 | 10.84 |
| 2011 | 22758.63 | 12596.20 | 35354.83 | 12.20 | 6.34 | 9.17 | 11.92 | 8.86 | 10.61 |
| 2012 | 18440.00 | 10022.20 | 28462.20 | 9.89 | 5.04 | 7.39 | 12.01 | 8.24 | 10.34 |
SEYLL—standard expected years of life lost; SEYLLp*10,000 = standard expected years of life lost per 10,000 living persons; SEYLLd = standard expected years of life lost per one dead person
Changes in the SEYLL, SEYLLp and SEYLLd indices due to infectious diseases in Poland in 1999–2012 by sex.
| Years of life lost | Number of joinpoints | Period | APC 95% CI | AAPC 95%CI | |
|---|---|---|---|---|---|
| SEYLL | Total | 0 | 1999–2012 | -0.79 (-1.8; 0.2) | |
| Men | 0 | 1999–2012 | -1.04* (-1.9; -0.2) | ||
| Women | 0 | 1999–2012 | -0.31(-1.7; 1.1) | ||
| SEYLLp*10,000 | Total | 0 | 1999–2012 | -0.81 (-1.8; 0.2) | |
| Men | 0 | 1999–2012 | -1.04*(-1.9; -0.1) | ||
| Women | 0 | 1999–2012 | -0.35 (-1.7; 1.0) | ||
| SEYLLd | Total | 1 | 1999–2008 | -1.52* (-2.0; -1.0) | -2.3* (-2.9; -1.7) |
| 2008–2012 | -4.12* (-5.9; -2.3) | ||||
| Men | 2 | 1999–2004 | -1.65* (-2.6; -0.7) | -1.6* (-2.5; -0.7) | |
| 2004–2007 | -0.02 (-4.3; 4.4) | ||||
| 2007–2012 | -2.57* (-3.5; -1.6) | ||||
| Women | 1 | 1999–2008 | -2.21* (-3.2; -1.2) | -3.4* (-4.5; -2.3) | |
| 2008–2012 | -6.02* (-9.3; -2.6) | ||||
* p<0.05; CI = Confidence interval; APC = Annual percentage change; AAPC = average annual percentage change
Estimated SEYLLp and SEYLLd values for infectious and parasitic diseases in European countries in 2012 by sex.
| Country | SEYLLp per 10,000 | SEYLLd | ||||||
|---|---|---|---|---|---|---|---|---|
| Males | Females | Total | Rank | Males | Females | Total | Rank | |
| Albania | 26,65 | 26,23 | 26,44 | 52,88 | 46,64 | 49,60 | ||
| Austria | 24,45 | 16,89 | 20,58 | 26,11 | 17,22 | 21,45 | ||
| Belarus | 130,73 | 42,79 | 83,63 | 48,32 | 49,86 | 48,73 | ||
| Belgium | 38,87 | 35,99 | 37,40 | 20,13 | 14,79 | 17,11 | ||
| Bosnia and Herzegovina | 27,82 | 17,39 | 22,48 | 31,11 | 25,33 | 28,54 | ||
| Bulgaria | 59,08 | 19,78 | 38,89 | 44,54 | 41,01 | 43,56 | ||
| Croatia | 23,66 | 14,33 | 18,83 | 28,41 | 21,35 | 25,14 | ||
| Cyprus | 23,47 | 14,54 | 19,10 | 21,46 | 16,85 | 19,47 | ||
| Czech Republic | 33,00 | 29,80 | 31,38 | 22,51 | 16,88 | 19,39 | ||
| Denmark | 34,14 | 28,68 | 31,39 | 20,42 | 15,03 | 17,53 | ||
| Estonia | 65,44 | 22,77 | 42,55 | 42,35 | 37,97 | 40,99 | ||
| Finland | 17,61 | 14,65 | 16,11 | 21,22 | 15,77 | 18,30 | ||
| France | 42,71 | 30,92 | 36,63 | 20,59 | 14,25 | 17,25 | ||
| Germany | 43,58 | 35,19 | 39,31 | 20,19 | 14,53 | 17,14 | ||
| Greece | 24,50 | 12,05 | 18,19 | 35,52 | 28,69 | 32,89 | ||
| Hungary | 21,55 | 16,39 | 18,84 | 27,67 | 19,20 | 23,03 | ||
| Iceland | 8,65 | 10,17 | 9,40 | 20,81 | 16,42 | 18,20 | ||
| Ireland | 20,30 | 16,46 | 18,37 | 29,40 | 22,15 | 25,61 | ||
| Italy | 41,07 | 29,27 | 35,00 | 21,94 | 16,00 | 18,92 | ||
| Latvia | 78,37 | 29,27 | 51,72 | 44,04 | 32,75 | 39,82 | ||
| Lithuania | 88,52 | 31,28 | 57,64 | 39,09 | 25,78 | 33,96 | ||
| Luxembourg | 33,22 | 33,79 | 33,49 | 20,44 | 17,36 | 18,75 | ||
| Malta | 15,59 | 13,35 | 14,46 | 43,66 | 32,23 | 37,53 | ||
| Montenegro | 14,19 | 7,04 | 10,57 | 34,58 | 28,62 | 32,31 | ||
| Netherlands | 27,82 | 24,71 | 26,25 | 20,02 | 16,02 | 17,90 | ||
| Norway | 32,48 | 29,89 | 31,19 | 16,62 | 12,36 | 14,27 | ||
| Poland | 22,56 | 8,07 | 15,06 | 36,26 | 30,37 | 34,41 | ||
| Portugal | 96,20 | 42,22 | 68,36 | 29,87 | 19,28 | 25,42 | ||
| Republic of Moldova | 136,59 | 29,99 | 80,53 | 47,34 | 48,26 | 47,51 | ||
| Romania | 68,75 | 24,46 | 46,03 | 38,38 | 34,23 | 37,15 | ||
| Serbia | 26,56 | 13,61 | 19,94 | 33,09 | 25,39 | 29,92 | ||
| Slovakia | 26,26 | 19,51 | 22,79 | 29,10 | 23,06 | 26,10 | ||
| Slovenia | 12,60 | 6,68 | 9,62 | 26,14 | 16,90 | 21,95 | ||
| Spain | 41,00 | 24,52 | 32,66 | 25,92 | 17,37 | 21,84 | ||
| Sweden | 41,95 | 40,20 | 41,08 | 15,65 | 13,27 | 14,39 | ||
| Switzerland | 23,04 | 17,38 | 20,17 | 21,11 | 16,23 | 18,66 | ||
| The former Yugoslav Republic of Macedonia | 14,68 | 9,20 | 11,94 | 39,72 | 38,20 | 39,12 | ||
| Ukraine | 415,09 | 177,19 | 286,85 | 45,34 | 46,78 | 45,81 | ||
| United Kingdom | 23,45 | 20,82 | 22,12 | 23,99 | 18,08 | 20,75 | ||
Source: [42] and [43]